Index -
P/E -
EPS (ttm) -1.34
Insider Own 57.57%
Shs Outstand 64.47M
Perf Week 0.72%
Market Cap 12.58B
Forward P/E 27.19
EPS next Y 7.28
Insider Trans 0.00%
Shs Float 26.96M
Perf Month -1.90%
Income -86.34M
PEG -
EPS next Q 1.46
Inst Own 46.09%
Short Float 5.48%
Perf Quarter -2.00%
Sales 1.06B
P/S 11.90
EPS this Y 15.38%
Inst Trans 17.11%
Short Ratio 7.14
Perf Half Y 10.37%
Book/sh 201.96
P/B 0.98
EPS next Y 10.34%
ROA -0.59%
Short Interest 1.48M
Perf Year -14.78%
Cash/sh 2.06
P/C 96.24
EPS next 5Y 17.00%
ROE -0.66%
52W Range 161.32 - 235.45
Perf YTD -10.06%
Dividend Est. -
P/FCF 46.00
EPS past 5Y -39.52%
ROI -0.67%
52W High -15.91%
Beta 0.76
Dividend TTM -
Quick Ratio 1.91
Sales past 5Y 4.12%
Gross Margin 39.21%
52W Low 22.74%
ATR (14) 5.06
Dividend Ex-Date Feb 15, 2024
Current Ratio 1.91
EPS Y/Y TTM -1117.98%
Oper. Margin -17.21%
RSI (14) 43.09
Volatility 2.19% 2.50%
Employees 3900
Debt/Eq 0.01
Sales Y/Y TTM 29.35%
Profit Margin -8.17%
Recom 2.55
Target Price 216.18
Option/Short Yes / Yes
LT Debt/Eq 0.01
EPS Q/Q 67.05%
Payout -
Rel Volume 0.90
Prev Close 197.11
Sales Surprise -3.14%
EPS Surprise -8.75%
Sales Q/Q 5.90%
Earnings May 07 AMC
Avg Volume 206.96K
Price 198.00
SMA20 -4.38%
SMA50 -0.45%
SMA200 1.83%
Trades
Volume 190,203
Change 0.45%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-01-23 Upgrade
Loop Capital
Hold → Buy
$180 → $213
Nov-14-23 Upgrade
Robert W. Baird
Neutral → Outperform
$194 → $202
Jul-26-23 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
Jul-21-23 Downgrade
Loop Capital
Buy → Hold
$240 → $170
Apr-27-23 Downgrade
William Blair
Outperform → Mkt Perform
Jan-11-23 Initiated
Berenberg
Hold
$210
Aug-17-22 Initiated
Wolfe Research
Peer Perform
Jul-07-22 Downgrade
Robert W. Baird
Outperform → Neutral
$170 → $162
Mar-17-22 Upgrade
Loop Capital
Hold → Buy
$175
Nov-19-21 Initiated
Loop Capital
Hold
$160
Oct-15-21 Initiated
Piper Sandler
Neutral
$170
Oct-12-21 Upgrade
BofA Securities
Neutral → Buy
$150 → $176
Aug-12-21 Downgrade
The Benchmark Company
Buy → Hold
Aug-12-21 Downgrade
JP Morgan
Neutral → Underweight
$144
Feb-03-21 Upgrade
Robert W. Baird
Neutral → Outperform
$135 → $165
Dec-15-20 Reiterated
The Benchmark Company
Buy
$130 → $155
Sep-23-20 Resumed
BofA Securities
Neutral
Aug-25-20 Initiated
Wolfe Research
Underperform
$112
Apr-02-20 Downgrade
Robert W. Baird
Outperform → Neutral
$110 → $100
Mar-16-20 Upgrade
JP Morgan
Underweight → Neutral
$112
Show Previous Ratings
Apr-17-24 09:00AM
Apr-16-24 04:05PM
Mar-19-24 08:46PM
Mar-07-24 11:31AM
Feb-28-24 09:01AM
08:00AM
Loading…
08:00AM
Feb-27-24 09:00AM
Feb-21-24 09:00AM
Feb-07-24 10:27AM
08:59AM
06:55AM
12:09AM
Feb-06-24 08:37PM
07:00PM
05:45PM
04:47PM
Loading…
04:47PM
(Associated Press Finance)
04:45PM
04:05PM
Feb-05-24 09:16AM
Feb-02-24 09:54AM
Jan-30-24 09:00AM
Jan-25-24 09:00AM
Jan-16-24 04:05PM
Dec-19-23 02:55AM
Dec-18-23 08:55PM
Dec-07-23 05:13PM
Dec-06-23 11:30AM
Dec-04-23 12:00PM
Nov-28-23 05:47AM
Nov-27-23 09:00AM
08:09AM
Loading…
Nov-15-23 08:09AM
Nov-14-23 09:00AM
Nov-07-23 10:51AM
10:12AM
06:55AM
12:11AM
12:04AM
Nov-06-23 06:00PM
05:27PM
04:29PM
(Associated Press Finance)
04:11PM
04:05PM
Oct-19-23 04:30PM
Oct-16-23 04:05PM
Oct-03-23 09:54AM
Oct-02-23 07:49AM
Sep-29-23 08:37AM
Sep-08-23 12:23PM
Sep-07-23 11:35AM
11:30AM
Sep-01-23 10:10AM
Aug-31-23 11:31AM
Aug-16-23 08:06AM
Aug-14-23 08:45AM
Aug-10-23 09:00AM
Aug-04-23 08:12AM
Aug-03-23 08:29AM
08:00AM
Aug-02-23 12:47PM
(Morningstar Research) +9.69%
06:55AM
Aug-01-23 08:00PM
06:45PM
05:47PM
04:05PM
Jul-28-23 09:06AM
Jul-26-23 09:40AM
Jul-25-23 10:01AM
Jul-11-23 04:05PM
Jul-05-23 11:00AM
Jun-21-23 08:00PM
May-26-23 11:31AM
08:22AM
May-24-23 06:30AM
May-17-23 10:42AM
08:00AM
May-16-23 06:00AM
May-05-23 07:30AM
May-03-23 06:51AM
May-02-23 09:08AM
07:48AM
Apr-29-23 08:02AM
Apr-27-23 03:31PM
03:03PM
11:41AM
Apr-26-23 08:00PM
06:05PM
04:05PM
Apr-12-23 04:05PM
Apr-06-23 07:22PM
Apr-04-23 11:34AM
08:34AM
Mar-16-23 04:05PM
08:37AM
Mar-15-23 09:00AM
Mar-09-23 11:30AM
Mar-08-23 11:30AM
Mar-07-23 09:00AM
Mar-06-23 08:47AM
Mar-03-23 11:30AM
Mar-02-23 11:30AM
Aspen Technology, Inc. engages in the development of software applications for asset performance and management monitoring. It operates through the following segments: OSI Inc., GSS Business, and Heritage AspenTech. The company was founded on August 12, 1981 and is headquartered in Bedford, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Whelan, Jr. Robert M. Director Jun 12 '23 Option Exercise 36.53 3,114 113,754 8,954 Jun 14 04:06 PM Whelan, Jr. Robert M. Director Jun 12 '23 Sale 164.56 3,114 512,440 5,840 Jun 14 04:06 PM Pietri Antonio J President & CEO May 30 '23 Option Exercise 83.15 4,806 399,617 167,323 Jun 01 04:11 PM
Index NDX, S&P 500
P/E -
EPS (ttm) -7.34
Insider Own 0.50%
Shs Outstand 159.00M
Perf Week 3.74%
Market Cap 19.23B
Forward P/E 49.49
EPS next Y 2.45
Insider Trans 0.89%
Shs Float 158.11M
Perf Month -9.53%
Income -1161.00M
PEG -
EPS next Q 0.04
Inst Own 90.68%
Short Float 3.34%
Perf Quarter -15.21%
Sales 4.50B
P/S 4.27
EPS this Y 2.09%
Inst Trans 2.72%
Short Ratio 3.19
Perf Half Y 4.26%
Book/sh 36.13
P/B 3.35
EPS next Y 178.57%
ROA -10.38%
Short Interest 5.27M
Perf Year -44.65%
Cash/sh 6.63
P/C 18.25
EPS next 5Y 22.90%
ROE -18.81%
52W Range 89.00 - 228.13
Perf YTD -13.06%
Dividend Est. -
P/FCF 68.21
EPS past 5Y -
ROI -14.66%
52W High -46.94%
Beta 1.21
Dividend TTM -
Quick Ratio 1.29
Sales past 5Y 7.40%
Gross Margin 60.97%
52W Low 36.01%
ATR (14) 4.83
Dividend Ex-Date -
Current Ratio 1.66
EPS Y/Y TTM 73.83%
Oper. Margin -1.62%
RSI (14) 41.27
Volatility 3.38% 3.63%
Employees 12010
Debt/Eq 0.39
Sales Y/Y TTM -1.72%
Profit Margin -25.78%
Recom 2.46
Target Price 151.55
Option/Short Yes / Yes
LT Debt/Eq 0.38
EPS Q/Q -24.92%
Payout -
Rel Volume 0.58
Prev Close 122.87
Sales Surprise 3.19%
EPS Surprise 652.69%
Sales Q/Q 3.60%
Earnings May 02 AMC
Avg Volume 1.66M
Price 121.05
SMA20 -4.32%
SMA50 -8.51%
SMA200 -13.08%
Trades
Volume 962,789
Change -1.48%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-16-24 Downgrade
HSBC Securities
Buy → Hold
Jan-04-24 Downgrade
TD Cowen
Outperform → Market Perform
$144
Dec-18-23 Upgrade
Scotiabank
Sector Perform → Sector Outperform
$185
Dec-15-23 Upgrade
Bernstein
Underperform → Mkt Perform
Dec-14-23 Initiated
Stephens
Overweight
$170
Dec-14-23 Initiated
Guggenheim
Buy
$155
Dec-13-23 Initiated
Wolfe Research
Outperform
$175
Dec-12-23 Downgrade
BofA Securities
Neutral → Underperform
$140 → $100
Dec-11-23 Upgrade
Citigroup
Sell → Neutral
$85 → $120
Nov-10-23 Downgrade
Canaccord Genuity
Buy → Hold
$210 → $120
Sep-28-23 Initiated
Bernstein
Underperform
$111
Jul-05-23 Resumed
JP Morgan
Neutral
$235
Jan-25-23 Downgrade
Argus
Buy → Hold
Jan-05-23 Initiated
Scotiabank
Sector Perform
$216
Dec-12-22 Downgrade
Citigroup
Neutral → Sell
$200 → $180
Dec-07-22 Initiated
RBC Capital Mkts
Outperform
$282
Oct-04-22 Upgrade
SVB Leerink
Mkt Perform → Outperform
$220 → $270
Sep-28-22 Upgrade
Evercore ISI
In-line → Outperform
$170 → $250
Aug-25-22 Initiated
Credit Suisse
Neutral
$230
Jul-13-22 Downgrade
Barclays
Equal Weight → Underweight
$350 → $150
Show Previous Ratings
Today 06:03AM
Apr-25-24 10:02AM
08:53AM
Apr-21-24 08:30AM
Apr-19-24 02:05PM
12:10PM
Loading…
12:10PM
Apr-18-24 01:30PM
08:00AM
Apr-17-24 09:30AM
Apr-15-24 05:40AM
Apr-12-24 09:00AM
06:21AM
05:49AM
Apr-10-24 08:16AM
Apr-09-24 11:37PM
05:28PM
Loading…
05:28PM
04:32PM
04:28PM
04:18PM
04:05PM
Apr-05-24 02:27PM
12:45PM
Apr-04-24 05:00PM
Apr-02-24 09:45AM
Mar-30-24 07:43PM
Mar-26-24 08:02AM
Mar-25-24 06:17AM
Mar-21-24 06:37PM
05:44AM
05:12AM
05:01AM
Loading…
05:01AM
Mar-18-24 12:40PM
Mar-17-24 08:50AM
Mar-14-24 07:42PM
Mar-13-24 06:43AM
Mar-12-24 04:50PM
02:41PM
01:57PM
Mar-08-24 08:45AM
Mar-07-24 03:00PM
08:45AM
Mar-02-24 02:30PM
Feb-28-24 05:52AM
Feb-27-24 03:40AM
03:09AM
Feb-26-24 06:29PM
11:00AM
Feb-24-24 06:50AM
Feb-23-24 07:59AM
Feb-21-24 07:42PM
09:00AM
Feb-20-24 10:25AM
Feb-14-24 07:00PM
09:40AM
Feb-09-24 11:19AM
07:52AM
(Thomson Reuters StreetEvents)
07:39AM
05:45AM
01:32AM
Feb-08-24 06:30PM
05:24PM
04:34PM
04:24PM
(Associated Press Finance)
04:05PM
09:14AM
Feb-05-24 09:16AM
Feb-01-24 09:10PM
Jan-30-24 07:31AM
Jan-29-24 07:49PM
Jan-28-24 09:25AM
Jan-23-24 08:45PM
Jan-19-24 08:25AM
Jan-18-24 07:52AM
05:04AM
Jan-17-24 12:04PM
Jan-16-24 10:11AM
Jan-15-24 07:00AM
Jan-12-24 09:45AM
Jan-11-24 09:45AM
Jan-09-24 05:28PM
02:02PM
09:00AM
07:05AM
05:38AM
03:34AM
Jan-08-24 12:45PM
Jan-05-24 09:15AM
Jan-04-24 08:17PM
04:05PM
09:15AM
Dec-28-23 01:02PM
Dec-27-23 10:45AM
Dec-22-23 03:00PM
Dec-21-23 09:35AM
Dec-19-23 05:28PM
(The Wall Street Journal) +8.08%
04:42PM
04:05PM
01:26PM
11:11AM
11:02AM
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Thaysen Jacob Chief Executive Officer Feb 22 '24 Buy 135.29 7,330 991,672 14,861 Feb 26 08:57 AM Hoyt Aimee L SVP, Chief People Officer Nov 07 '23 Sale 112.84 315 35,545 8,314 Nov 09 04:22 PM TOUSI SUSAN H SVP, Chief Commercial Officer Aug 22 '23 Sale 167.04 500 83,520 45,524 Aug 24 04:19 PM TOUSI SUSAN H SVP, Chief Commercial Officer Jul 24 '23 Sale 190.08 500 95,040 46,022 Jul 26 06:14 PM TOUSI SUSAN H SVP, Chief Commercial Officer Jun 22 '23 Sale 200.00 500 100,000 46,522 Jun 26 05:23 PM EPSTEIN ROBERT S Director May 25 '23 Option Exercise 71.09 7,600 540,284 14,764 May 25 04:34 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite